Sutro Biopharma Inc at Needham Healthcare Conference Transcript
Good afternoon and welcome to day four of the Needham & Company healthcare conference. My name is Gil Blum and I am a senior biotech analyst here at Needham & Company. It is my pleasure to have with me today Bill Newell, CEO of Sutro Biopharma. (Conference Instructions). And with that, Bill, you have the floor.
Thanks, Gil, very much and thanks to Needham for inviting me to talk about Sutro Biopharma today. In the course of today's conversation I'm going to be making some forward-looking statements. Those forward-looking statements are referenced here and, if you need to know more information about them, please look for our public disclosures in that regard.
For those of you who are familiar with Sutro Biopharma, you probably think of us as an antibody drug conjugate company and that is partially correct. But actually Sutro is a next-generation cancer company with four therapeutics in the clinic and one vaccine that is also in the clinic. Our technology enables,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
